Table 4.
Specifically selected anomalies (ICD-10) | N and prevalence × 10.000 (CI 95%) | ad PRR PUB (IC95%) | Specific selected anomalies (ICD-10) | N and prevalence × 10.000 (CI 95%) | ad PRR PUB (IC95%) |
||
---|---|---|---|---|---|---|---|
PRI | PUB | PRI | PUB | ||||
Anencephaly (Q00) |
21 1.02 (0.63–1.55) |
565 2.83 (2.60–3.07) |
2.80 * (1.71–4.58) |
Transverse limb reduction defect (Q71.2–Q71.30) |
27 1.31 (0.86–1.90) |
345 1.73 (1.56–1.92) |
1.32 (0.88–2.01) |
Encephalocele (Q01) |
11 0.53 (0.27–0.95) |
264 1.32 (1.17–1.49) |
2.50 * (1.10–5.65) |
Equinovarus Talipes (Q66.0) |
71 3.43 (2.68–4.33) |
1389 6.96 (6.60–7.33) |
2.04 * (1.30–3.19) |
Spina bifida (Q05) |
104 5.03 (4.11–6.09) |
1118 5.60 (5.28–5.94) |
1.12 (0.57–2.18) |
Calcaneovalgus Talipes (Q66.4) |
6 0.29 (0.11–0.63) |
188 0.94 (0.81–1.09) |
3.26* (1.17–9.09) |
Hydrocephaly (Q03) |
98 4.74 (3.85–5.77) |
1512 7.58 (7.20–7.97) |
1.61 * (1.14–2.27) |
Esophageal atresia (Q39.0–Q39.11) |
62 3.00 (2.30–3.84) |
672 3.37 (3.12–3.63) |
1.13 (0.83–1.54) |
Holoprosencephaly (Q04.1-04.2) |
14 0.68 (0.37–1.14) |
495 2.48 (2.27–2.71) |
3.68 * (2.06–6.56) |
Intestinal atresia (Q41.1–Q41.9) |
26 1.26 (0.82–1.84) |
338 1.69 (1.52–1.88) |
1.35 (0.91–2.09) |
Microcephaly (Q02) |
25 1.21 (0.78–1.78) |
499 2.50 (2.29–2.73) |
2.08 * (1.36–3.16) |
Duodenal atresia (Q41.0) |
44 2.13 (1.55–2.86) |
337 1.69 (1.51–1.88) |
0.80 (0.55–1.15) |
Microphthalmia / anophthalmia (Q11.1-11.2) |
24 1.16 (0.74–1.73) |
271 1.36 (1.20–1.53) |
1.18 (0.78–1.77) |
Anorectal malformation (Q42.0–Q42.3) |
84 4.06 (3.24–5.03) |
976 4.89 (4.59–5.21) |
1.21 (0.92–1.60) |
Anotia + microtia (Q16; Q17.1) |
37 1.79 (1.26–2.47) |
596 2.99 (2.75–3.24) |
1.61 * (1.02–2.56) |
Diaphragmatic hernia (Q79.0–Q79.01) |
73 3.53 (2.77–4.44) |
747 3.74 (3.48–4.02) |
1.06 (0.51–2.24) |
Cleft Palate (Q35) |
63 3.05 (2.34–3.90) |
426 2.13 (1.94–2.35) |
1.03 (0.79–1.36) |
Gastroschisis (Q79.3) |
76 3.67 (2.90–4.60) |
1657 8.30 (7.91–8.71) |
2.27 * (1.50–3.44) |
Cleft Lip (Q36; exclude Q36.1, medial) |
32 1.55 (1.06–2.18) |
412 2.01 (1.87–2.27) |
1.34 (0.93–1.92) |
Omphalocele (Q79.2) |
38 1.84 (1.30–2.52) |
432 2.16 (1.97–2.38) |
1.18 (0.79–1.77) |
Cleft lip and palate (Q37) |
138 6.67 (5.60–7.88) |
2099 10.5 (10.1–11.0) |
1.58 * (1.24–2.03) |
Bilateral Cryptorchidism (Q53.2) |
26 1.26 (0.82–1.84) |
220 1.10 (0.96–1.26) |
0.88 (0.47–1.64) |
Coarctation of the Aorta (Q25.1-Q25.19) |
57 2.76 (2.09–3.57) |
360 1.80 (1.62–2.00) |
0.66 * (0.47–0.92) |
Ambiguous genitalia (Q56.4) |
24 1.16 (0.74–1.73) |
319 1.60 (1.43–1.78) |
1.38 (0.97–1.96) |
Hypoplasic left heart (Q23.4) |
60 2.90 (2.21–3.73) |
342 1.71 (1.54–1.91) |
0.59 * (0.45–0.79) |
Hypospadias (Q54.1–Q54.3) |
86 4.16 (3.33–5.13) |
496 2.49 (2.27–2.71) |
0.60 * (0.40–0.91) |
Tetralogy of Fallot (Q21.3-Q21.87) |
66 3.19 (2.47–4.06) |
369 1.85 (1.67–2.05) |
0.58 * (0.40–0.83) |
Bilateral renal agenesis (Q60.1) |
10 0.83 (0.23–0.89) |
174 0.87 (0.74–1.01) |
1.81 (0.87–3.79) |
Transposition of the great vessels (Q20.3) |
63 3.05 (2.34–3.40) |
365 1.83 (1.65–2.03) |
0.60 * (0.38–0.95) |
Renal cysts (Q61.1–Q61.90) |
65 3.14 (2.43–4.01) |
818 4.10 (3.82–4.39) |
1.31 (0.90–1.90) |
Double inlet left ventricle (Q20.4) |
21 1.02 (0.63–1.55) |
240 1.20 (1.06–1.36) |
1.19 (0.72–1.95) |
Down syndrome (Q90.0–90.9) |
422 20.4 (18.5–22.4) |
3391 17.0 (16.4–17.6) |
0.83 * (0.71–0.98) |
Preaxial polydactyly (Q69.00; Q69.1; Q69.20) |
22 1.06 (0.67–1.61) |
300 1.50 (1.34–1.68) |
1.42 (0.88–2.30) |
Edwards syndrome (Q91.0) |
53 2.56 (1.92–3.35) |
227 1.14 (0.99–1.30) |
0.45 * (0.28–0.70) |
Postaxial polydactyly (Q69.02; Q69.22) |
52 2.51 (1.88–3.30) |
1056 5.29 (4.98–5.62) |
2.11 * (1.23–3.61) |
Patau syndrome (Q91.4) |
18 0.87 (0.21–1.38) |
88 0.44 (0.35–0.54) |
0.51 * (0.29–0.89) |
PRR prevalence rate ratio of being born in PUB hospital
*Statistically significant